← Back to Search

Web-based IVF Education for Patient Understanding (WebIVF Trial)

N/A
Waitlist Available
Led By Tannys DR Vause, MD
Research Sponsored by Ottawa Fertility Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject >18 years of age
English speaking and reading
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed prior to consenting to ivf treatment and after teaching intervention (within 6-8 weeks)
Awards & highlights

WebIVF Trial Summary

This trial is testing whether an IVF web-based teaching tool is better than a didactic lecture in teaching patients, reducing stress, and increasing satisfaction.

Who is the study for?
This trial is for adults over 18 who are English-speaking, can consent, have internet access, and are undergoing their first IVF cycle. It's not for those who've had previous IVF treatments or teaching sessions, or haven't completed a baseline knowledge questionnaire.Check my eligibility
What is being tested?
The study compares an interactive web-based teaching tool with a traditional didactic lecture for educating IVF patients. Participants will be randomly assigned to one of the two methods and evaluated on knowledge gain, stress levels, and satisfaction during their treatment cycle.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there aren't typical side effects like you'd expect from medication. However, participants may experience varying levels of stress or satisfaction with the different teaching methods.

WebIVF Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I can speak and read English.

WebIVF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed prior to consenting to ivf treatment and after teaching intervention (within 6-8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed prior to consenting to ivf treatment and after teaching intervention (within 6-8 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To assess knowledge in IVF patients after completing either a web-based teaching module or traditional teaching session
Secondary outcome measures
To assess satisfaction in IVF patients after completing either a web-based teaching module or traditional teaching session
To assess stress levels in IVF patients after completing either a web-based teaching module or traditional teaching session

WebIVF Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Web-based Teaching GroupExperimental Treatment4 Interventions
Patients randomized to the intervention group will receive a unique login and password to a link on the Ottawa Fertility Centre website. This will allow them access to a secure site containing required teaching modules. They will then complete an interactive teaching tool that contains the same educational content as the traditional presentation. Patients will be able to access a module that is specific to their stimulation protocol. The teaching tool does not need to be completed all at one time. Once completed, the information can still be accessed as many times as required.
Group II: Control groupActive Control4 Interventions
Participants randomized to the control arm of the study will participate in a traditional didactic teaching session. This session will be carried out by the nurse educator. This session will be attended by up to 10 other couples that may or may not be participating in the study. The nurse educator administering the session will not know which couples are participating in the study. Slides shown and information conveyed will be the same as that provided to the web-based group, however all three stimulation protocols will be presented to the participants regardless of their actual treatment protocol.

Find a Location

Who is running the clinical trial?

Ottawa Fertility CentreLead Sponsor
3 Previous Clinical Trials
268 Total Patients Enrolled
Schering-PloughIndustry Sponsor
162 Previous Clinical Trials
41,480 Total Patients Enrolled
Mark Evans, MBAStudy DirectorOttawa Fertiilty Centre

Media Library

Didactic lecture 2023 Treatment Timeline for Medical Study. Trial Name: NCT01046188 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research experiment recruiting participants?

"The clinicaltrials.gov database indicates that this particular trial is no longer accepting patients, as it was first posted on the 1st of January 2010 and last modified on 14th of same month. Nevertheless, there are presently 20 other trials open for enrollment."

Answered by AI

Who else is applying?

What state do they live in?
Alabama
Texas
North Carolina
How old are they?
18 - 65
What site did they apply to?
Ottawa Fertility Centre
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

How responsive is this trial?

Typically responds via
Email
~3 spots leftby Apr 2025